BIOENTERPRISE CORPORATION (EIN 341947257) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2000

Legal Domicile

Principal Officer

JOHN K LANE

Phone

2166583999

Tax Period

2023-07-01 to 2024-06-30

BIOENTERPRISE CORPORATION, founded in 2000, is a micro nonprofit in the Community Improvement sector that reported $1K in total revenue in fiscal year 2023. Revenue fell 100% from the prior year — a significant decline worth monitoring. Expenses of $235K exceeded revenue, resulting in a 20389% operating deficit.

Mission

TO FOSTER ECONOMIC DEVELOPMENT AND COMMERCIALIZE BIOSCIENCE TECHNOLOGIES TO IMPROVE PUBLIC HEALTH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $926

Other Revenue $223

TOTAL REVENUE $1,149

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $143,242

Other Expenses $235,414

TOTAL EXPENSES $235,414

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,149	$4,354,711	-1.0%
Expenses	$235,414	$4,607,968	-0.9%
Net Income	$-234,265	$-253,257	-0.1%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN LANE	PRESIDENT, SECRETARY AND T	1.00	Officer Director	$0	$0	$0
PETER POULOS	DIRECTOR	1.00	Director	$0	$0	$0
JOSEPH RICH	DIRECTOR	1.00	Director	$0	$0	$0
DAVID SYLVAN	DIRECTOR	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$1,149	$235,414	$375,828	$-234,265
2023	$4,354,711	$4,607,968	$610,093	$-253,257
2022	$1,921,063	$1,483,634	$2,389,424	$437,429
2021	$2,005,223	$2,675,188	$2,531,448	$-669,965
2020	$3,833,224	$7,190,613	$3,292,122	$-3,357,389
2019	$5,168,128	$6,450,887	$6,338,782	$-1,282,759
2018	$5,493,690	$5,949,115	$7,743,458	$-455,425

BIOENTERPRISE CORPORATION